** Lanxess LXSG.DE falls 9% after it posted its Q2 EBITDA outlook below expectations
** The German speciality chemicals company said it expects EBITDA in Q2 of between 130 and 150 million euros, with Jefferies highlighting an 11% miss of the midpoint of a Visible Alpha-compiled analysts consensus
** Analysts had anticipated "strong" upside potential in the Q2, as Metzler points to price increases in Q1, improving order momentum since March and reduced competition from Asia due to the Middle East conflict
** "Given weaker than expected 2Q guidance, we believe the stock will likely underperform this morning, with the focus to be on any more qualitative comments on near-term trading on the conference call," J.P. Morgan says
(Reporting by Danny Callaghan)
((danny.callaghan@thmosonreuters.com))